Jonathan A. G. Cox
Jonathan A. G. Cox
Lecturer in Microbiology, Aston University, UK
Verified email at aston.ac.uk - Homepage
TitleCited byYear
Assembly of the Mycobacterial Wall
M Jankute, JAG Cox, J Harrison, GS Besra
Annual Review of Microbiology 69, 2015
1652015
Identification of novel imidazo [1, 2-a] pyridine inhibitors targeting M. tuberculosis QcrB
KA Abrahams, JAG Cox, VL Spivey, NJ Loman, MJ Pallen, ...
PloS one 7 (12), 2012
1372012
THPP target assignment reveals EchA6 as an essential fatty acid shuttle in mycobacteria
JAG Cox, KA Abrahams, C Alemparte, S Ghidelli-Disse, J Rullas, ...
Nature Microbiology, doi:10.1038/nmicrobiol.2015.6, 2016
352016
Mycobacterial Dihydrofolate Reductase Inhibitors Identified Using Chemogenomic Methods and
G Mugumbate, KA Abrahams, JAG Cox, G Papadatos, G van Westen, ...
journal.pone.0121492 10, (3): e0121492. doi:10.1371, 2015
30*2015
Identification of KasA as the cellular target of an anti-tubercular scaffold
KA Abrahams, C Chung, S Ghidelli-Disse, J Rullas, MJ Rebollo-López, ...
Nature communications 7 (1), 1-13, 2016
292016
Novel inhibitors of Mycobacterium tuberculosis GuaB2 identified by a target based high-throughput phenotypic screen
JAG Cox, G Mugumbate, LVGD Peral, M Jankute, KA Abrahams, P Jervis, ...
Scientific Reports 6 (38986), doi: 10.1038/srep38986, 2016
182016
Biochemical and structural characterization of mycobacterial aspartyl-tRNA synthetase AspS, a promising TB drug target
SS Gurcha, V Usha, JAG Cox, K Fütterer, KA Abrahams, A Bhatt, ...
PloS one 9 (11), 2014
182014
Inhibiting mycobacterial tryptophan synthase by targeting the inter-subunit interface
KA Abrahams, JAG Cox, K Fütterer, J Rullas, F Ortega-Muro, NJ Loman, ...
Scientific reports 7 (1), 1-15, 2017
162017
Antimycobacterial drug discovery using Mycobacteria-infected amoebae identifies anti-infectives and new molecular targets
V Trofimov, S Kicka, S Mucaria, N Hanna, F Ramon-Olayo, LVG Del Peral, ...
Scientific reports 8 (1), 3939, 2018
142018
Mycobacterium abscessus: environmental bacterium turned clinical nightmare
RC Lopeman, J Harrison, M Desai, JAG Cox
Microorganisms 7 (3), 90, 2019
122019
The ‘Antibiotic Apocalypse’–Scaremongering or Scientific Reporting?
JAG Cox, T Worthington
Trends in microbiology 25 (3), 167-169, 2017
102017
Modelling a silent epidemic: a review of the in vitro models of latent tuberculosis
SER Gibson, J Harrison, JAG Cox
Pathogens 7 (4), 88, 2018
52018
The drugs don't work: evaluation of educational theatre to gauge and influence public opinion on antimicrobial resistance
R Ahmed, A Bashir, JEP Brown, JAG Cox, AC Hilton, CE Hilton, ...
Journal of Hospital Infection 104 (2), 193-197, 2020
12020
Crystal structure of Mycobacterium tuberculosis FadB2 implicated in mycobacterial β-oxidation
JAG Cox, RC Taylor, AK Brown, S Attoe, GS Besra, K Fütterer
Acta Crystallographica Section D: Structural Biology 75 (1), 101-108, 2019
12019
Effect of Amoxicillin in combination with Imipenem-Relebactam against Mycobacterium abscessus
RC Lopeman, J Harrison, DL Rathbone, M Desai, PA Lambert, JAG Cox
Scientific Reports 10 (1), 1-10, 2020
2020
Dissecting the Antimicrobial Composition of Honey
VC Nolan, J Harrison, JAG Cox
Antibiotics 8 (4), 251, 2019
2019
Changing the Rules of TB-Drug Discovery
J Harrison, JAG Cox
Journal of medicinal chemistry 62 (23), 10583-10585, 2019
2019
Drug development: The cell wall as a drug target
JAG Cox
International journal of mycobacteriology 5 (5), 156, 2016
2016
Identifying the mode of action of novel anti-tubercular drugs
JAG Cox
University of Birmingham, 2015
2015
Targeting M. tuberculosis QcrB
KA Abrahams, JAG Cox, VL Spivey, NJ Loman, MJ Pallen, ...
2012
The system can't perform the operation now. Try again later.
Articles 1–20